-
1Academic Journal
المؤلفون: Ntinginya, NE, Te Brake, L, Sabi, I, Chamba, N, Kilonzo, K, Laizer, S, Andia-Biraro, I, Kibirige, D, Kyazze, AP, Ninsiima, S, Critchley, JA, Romeo, R, van de Maat, J, Olomi, W, Mrema, L, Magombola, D, Mwayula, IH, Sharples, K, Hill, PC, van Crevel, R, PROTID Consortium
وصف الملف: application/pdf; application/msword
Relation: https://openaccess.sgul.ac.uk/id/eprint/114437/3/s13063-022-06296-8.pdf; https://openaccess.sgul.ac.uk/id/eprint/114437/1/Revised%20PROTID%20Protocol%20Manuscript%20dated%2008-April-%202022.doc; Ntinginya, NE; Te Brake, L; Sabi, I; Chamba, N; Kilonzo, K; Laizer, S; Andia-Biraro, I; Kibirige, D; Kyazze, AP; Ninsiima, S; et al. Ntinginya, NE; Te Brake, L; Sabi, I; Chamba, N; Kilonzo, K; Laizer, S; Andia-Biraro, I; Kibirige, D; Kyazze, AP; Ninsiima, S; Critchley, JA; Romeo, R; van de Maat, J; Olomi, W; Mrema, L; Magombola, D; Mwayula, IH; Sharples, K; Hill, PC; van Crevel, R; PROTID Consortium (2022) Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial. Trials, 23 (1). p. 480. ISSN 1745-6215 https://doi.org/10.1186/s13063-022-06296-8 SGUL Authors: Critchley, Julia
-
2Academic Journal
المؤلفون: Mrema, L., Laizer, S. Naftal, Chamba, N., Kilonzo, K., Sabi, I., Ntinginya, N. Elias, Temba, G., van Crevel, R.
المصدر: Diabetes Research and Clinical Practice ; volume 209, page 111183 ; ISSN 0168-8227
-
3Academic Journal
المؤلفون: Laizer, S., Mrema, L., Kyazze, A., Chamba, N., Kilonzo, K., Olomi, W., Ntinginya, N., Kibirige, D., Andia-Biraro, I., Critchley, J., Hill, P., Crevel, R.
المصدر: Diabetes Research and Clinical Practice ; volume 209, page 111495 ; ISSN 0168-8227
-
4Periodical
المؤلفون: Laizer, Sheri
المصدر: Listener (Wellington, N.Z.), 4 Jun 1988; v.121 n.2519:p.30-33
New Zealand listener -
5Periodical